Daptomycin combinations as alternative therapies in experimental foreign-body infection caused by

Cristina El Haj1, Oscar Murillo1, Alba Ribera1

  • 1Laboratory of Experimental Infection, Infectious Diseases Service, IDIBELL, Hospital Universitari de Bellvitge, Feixa Llarga s/n, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.

Insights

Daptomycin plus rifampicin (DAP+RIF) and daptomycin plus levofloxacin (DAP+LVX) are effective alternatives for prosthetic joint infections caused by MSSA. DAP+RIF showed superior efficacy and prevented antibiotic resistance.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Microbiology

Background:

  • Prosthetic joint infections (PJI) caused by meticillin-susceptible Staphylococcus aureus (MSSA) typically use levofloxacin (LVX) and rifampicin (RIF).
  • Limited therapeutic alternatives exist for MSSA PJI, necessitating evaluation of novel combinations.
  • Daptomycin (DAP) has shown efficacy against meticillin-resistant S. aureus (MRSA) PJI, suggesting potential for MSSA treatment.

Purpose of the Study:

  • To evaluate the efficacy of daptomycin plus rifampicin (DAP+RIF) and daptomycin plus levofloxacin (DAP+LVX) as alternative therapies for foreign-body infections (FBIs) caused by MSSA.
  • To compare the efficacy of these combinations against monotherapies and assess the emergence of antibiotic resistance.

Main Methods:

  • A rat tissue-cage infection model using an MSSA strain was employed.
  • Animals were treated with monotherapies (LVX, DAP, RIF) or combination therapies (LVX+RIF, DAP+RIF, DAP+LVX) for 7 days.
  • Efficacy was assessed by bacterial counts in tissue cage fluid (TCF) and cure rates based on adhered bacteria; resistance screening was performed.

Main Results:

  • Combination therapies were significantly more effective than monotherapies (P<0.05).
  • DAP+RIF demonstrated the highest efficacy with a -4.9logCFU/mL decrease in bacterial counts and a 92% cure rate.
  • DAP+LVX (47% cure rate) and LVX+RIF (11% cure rate) showed varied efficacy, with no resistance emerging in combined therapies.

Conclusions:

  • Daptomycin-based combinations, particularly DAP+RIF, are effective alternative therapies for MSSA FBIs, including PJI.
  • DAP+RIF exhibited superior efficacy compared to LVX+RIF and prevented the emergence of antibiotic resistance.
  • Further research is warranted to explore DAP+RIF as a potential first-line treatment for MSSA PJI.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
52
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
7.9K
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
132
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
89
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
66
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
3.6K